You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 96 No. 3, SEPTEMBER 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical States Associated with Alterat of the Hemoglobin Molecule

The Minot Lecture

HARVEY A. ITANO, M.D., Ph.D.

AMA Arch Intern Med. 1955;96(3):287-297.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The role played by Dr. William B. Castle, the first Minot lecturer, in stimulating the initial studies of hemoglobin in sickle-cell anemia is not generally known. It was his description, in 1945, of the effect of oxygen and carbon dioxide on sickling, in Dr. Linus Pauling's presence, which prompted Dr. Pauling to postulate that an abnormal hemoglobin was present in the sickling cells.1 The following year, Dr. Pauling suggested that I begin the investigation which culminated in the detection of an inherited abnormal hemoglobin in sickle-cell anemia and sickle-cell trait.2 By 1951 two more abnormal hemoglobins (Figs. 1-5) were found to be associated with sicklecell disease.* By 1953, ten distinct hereditary clinical states were known to be associated with abnormal hemoglobin metabolism.5 During the past year five more abnormal hemoglobins have been found,{dagger} two in clinical states resembling Cooley's anemia {ddagger} and two in asymptomatic states.§ While part of what . . . [Full Text PDF of this Article]


Author Affiliations

Bethesda, Md.

Clinical Biochemical Research Section, Laboratory of Biochemistry, National Cancer Institute, National Institutes of Health.


Footnotes

Submitted for publication June 30, 1955.

Read before the Section on Experimental Medicine and Therapeutics at the 104th Annual Meeting of the American Medical Association, Atlantic City, June 8, 1955.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.